Sernova Biotherapeutics, Seraxis Holdings, BetaNova Biotherapeutics, SR-02, SR-03, Type 1 Diabetes, T1D, Cell Therapy, Islet Cell Therapy, Stem Cell-Derived Islets,

TORONTO and GERMANTOWN, Md. — October 5, 2026 Sernova Biotherapeutics Inc. and Seraxis Holdings, Inc. announced the closing of...